Quick Takeaways
- This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 09 Mar 2022, 15:36.
J. E. Davis - 07 Mar 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Signature
- /s/ William J. O'Shaughnessy, Jr., attorney-in-fact for James E. Davis
- Issuer symbol
- DGX
- Transactions as of
- 07 Mar 2022
- Net transactions value
- +$1,239,237
- Form type
- 4
- Filing time
- 09 Mar 2022, 15:36:35 UTC
- Previous filing
- 28 Feb 2022
- Next filing
- 03 Nov 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 09 Mar 2022."
What Changed
- Previous filing in this sequence was filed on 28 Feb 2022.
- Current net transaction value: +$1,239,237.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGX | Common Stock | Award | $2,583,067 | +19,856 | +35% | $130.09 | 77,138 | 07 Mar 2022 | Direct | F1 |
| transaction | DGX | Common Stock | Tax liability | $1,343,830 | -10,330 | -13% | $130.09 | 66,808 | 07 Mar 2022 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). |
| F2 | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. |